After Skyrocketing More Than 559% Over the Past Year, Can Oklo Stock Continue Powering Higher?

Oklo (OKLO), a developer of small modular nuclear reactors (SMRs), has seen its stock surge 559.6% over the past year, driven by several key catalysts. These include significant demand from data center customers, with letters of intent for up to 750 MW and a nonbinding agreement with Switch for 12 GW by 2044, capitalizing on the escalating power requirements of AI. The company's growth is further supported by strong political backing for nuclear energy and its expansion into the radioisotopic production market via its Atomic Alchemy subsidiary, a sector projected to reach $953 billion by 2032, alongside positive regulatory developments with the U.S. NRC.

Analysis

Oklo (OKLO) has demonstrated significant stock appreciation, surging 559.6% over the past year, underpinned by a convergence of powerful secular and company-specific catalysts. The primary driver is the escalating power demand from the artificial intelligence sector, evidenced by letters of intent from data center clients for 750 MW of capacity and a substantial non-binding agreement with Switch for 12 gigawatts through 2044. This aligns with forecasts projecting global data center spending to reach $1.1 trillion by 2029. This commercial momentum is amplified by a favorable political and regulatory environment, highlighted by recent executive orders supporting the nuclear industry and the U.S. Nuclear Regulatory Commission's decision to review Oklo's report, a critical step toward licensing its Aurora SMRs. Furthermore, the company is diversifying into the high-growth radioisotope production market through its subsidiary, Atomic Alchemy. This market is projected to grow at an 89.7% CAGR to $953 billion by 2032, representing a substantial secondary growth vector beyond power generation.

Key Decisions for Investors

• Given the stock's significant run-up and speculative nature, investors should view Oklo as a high-risk, high-reward position suitable only for portfolios with a high tolerance for volatility.
• Monitor key execution milestones for validation of the investment thesis, specifically the conversion of non-binding agreements into firm contracts, tangible progress in the NRC's regulatory approval process, and developments at the Idaho radioisotopic production facility.
• Investors should track the broader political and legislative landscape, as sustained policy support for nuclear energy is a critical enabler for Oklo's long-term project viability and financing.